Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | caspase 1, apoptosis-related cysteine peptidase | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | sphingomyelin phosphodiesterase 1, acid lysosomal | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Starlite/ChEMBL | No references |
Homo sapiens | caspase 7, apoptosis-related cysteine peptidase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0217 | 0.4204 | 1 |
Echinococcus granulosus | caspase | 0.0141 | 0.2487 | 0.2476 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0057 | 0.0572 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Echinococcus granulosus | caspase 8 | 0.0053 | 0.0488 | 0.0475 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0053 | 0.0488 | 0.0475 |
Echinococcus granulosus | geminin | 0.0205 | 0.3929 | 0.3921 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.1542 | 0.1542 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0038 | 0.0139 | 0.0126 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0103 | 0.162 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.0488 | 0.5 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.013 | 0.2237 | 0.8342 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0038 | 0.0139 | 0.03 |
Loa Loa (eye worm) | hypothetical protein | 0.0103 | 0.162 | 0.162 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0145 | 0.2567 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0014 | 0.0014 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.1542 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0261 | 0.0248 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0941 | 0.0929 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0057 | 0.0572 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0057 | 0.0572 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0145 | 0.2567 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0941 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Echinococcus multilocularis | caspase 8 | 0.0053 | 0.0488 | 0.0475 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0141 | 0.2487 | 0.2476 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0941 | 0.0929 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0941 | 0.0929 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.1145 | 0.1145 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3929 | 0.3921 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0405 | 0.0405 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0014 | 0.0014 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.0488 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0057 | 0.0572 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0139 | 0.0126 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.2012 | 0.2012 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0038 | 0.0139 | 0.0139 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0941 | 0.0929 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0053 | 0.0488 | 0.5 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.0141 | 0.2487 | 0.2476 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.013 | 0.2237 | 0.8342 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0038 | 0.0139 | 0.03 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0941 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0057 | 0.0572 | 0.0572 |
Brugia malayi | Thioredoxin reductase | 0.0057 | 0.0572 | 0.1332 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0941 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0014 | 0.0014 |
Plasmodium falciparum | glutathione reductase | 0.0057 | 0.0572 | 1 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.1542 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.0488 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0141 | 0.2487 | 0.2476 |
Brugia malayi | Cell death protein 3 precursor | 0.0103 | 0.162 | 0.3834 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0261 | 0.0248 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0261 | 0.0248 |
Echinococcus multilocularis | geminin | 0.0205 | 0.3929 | 0.3921 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0471 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0261 | 0.0591 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0057 | 0.0572 | 0.0559 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.0405 | 0.0392 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0471 | 1 | 1 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.005 | 0.0405 | 0.0392 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0145 | 0.2567 | 1 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0141 | 0.2487 | 0.2476 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0941 | 0.5 |
Echinococcus multilocularis | caspase 3 | 0.0088 | 0.1271 | 0.1259 |
Echinococcus multilocularis | GPCR, family 2 | 0.0038 | 0.0139 | 0.0126 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.005 | 0.0405 | 0.0392 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.0488 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0057 | 0.0572 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0038 | 0.0139 | 0.0126 |
Leishmania major | trypanothione reductase | 0.0057 | 0.0572 | 0.1849 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0941 | 0.5 |
Echinococcus granulosus | caspase 3 | 0.0088 | 0.1271 | 0.1259 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.013 | 0.2237 | 0.8342 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0261 | 0.0248 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0038 | 0.0139 | 0.0126 |
Mycobacterium tuberculosis | Probable reductase | 0.013 | 0.2237 | 0.8342 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0139 | 0.0126 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0057 | 0.0572 | 0.0559 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.0488 | 0.5 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0053 | 0.0488 | 0.1132 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0057 | 0.0572 | 0.0572 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0139 | 0.0126 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0145 | 0.2567 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.1145 | 0.1133 |
Echinococcus multilocularis | caspase | 0.0141 | 0.2487 | 0.2476 |
Echinococcus multilocularis | caspase 2 | 0.0103 | 0.162 | 0.1609 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.012 | 0.2012 | 0.4769 |
Echinococcus granulosus | caspase 2 | 0.0103 | 0.162 | 0.1609 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0103 | 0.162 | 0.1609 |
Brugia malayi | hypothetical protein | 0.005 | 0.0405 | 0.0933 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0038 | 0.0139 | 0.0126 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.012 | 0.2012 | 0.2012 |
Brugia malayi | glutathione reductase | 0.0057 | 0.0572 | 0.1332 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0488 | 0.0488 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0471 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0082 | 0.1145 | 0.2701 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3929 | 0.3921 |
Onchocerca volvulus | 0.005 | 0.0405 | 0.2434 | |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0941 | 0.185 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.013 | 0.2237 | 0.8342 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.0488 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0139 | 0.0139 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.012 | 0.2012 | 0.4769 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.013 | 0.2237 | 0.8342 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0139 | 0.0126 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0038 | 0.0139 | 0.0126 |
Toxoplasma gondii | thioredoxin reductase | 0.0057 | 0.0572 | 0.1849 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | 69.509 uM | PubChem BioAssay. Fluorescence Intensity-based biochemical primary high throughput dose response assay to identify activators of kallikrein-7 (K7) zymogen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.092 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 0.9196 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 75.6863 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.